Daewoong Pharmaceutical Co., Ltd's latest marketcap:
As of 06/18/2025, Daewoong Pharmaceutical Co., Ltd's market capitalization has reached $1.3 B. According to our data, Daewoong Pharmaceutical Co., Ltd is the 8022th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 1.3 B |
| Revenue (ttm) | 1.04 B |
| Net Income (ttm) | 27.82 M |
| Shares Out | 11.51 M |
| EPS (ttm) | 2.42 |
| Forward PE | 14.71 |
| Ex-Dividend Date | 12/27/2024 |
| Earnings Date | 08/14/2025 |
Daewoong Pharmaceutical Co., Ltd's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/18/2025 | ₩1.3 B | 23.42% | 8022 |
| 12/30/2024 | ₩1.45 T | 8.22% | 8943 |
| 12/28/2023 | ₩1.34 T | -23.4% | 8464 |
| 12/29/2022 | ₩1.75 T | 7.09% | 6768 |
| 12/30/2021 | ₩1.64 T | -7.75% | 7696 |
| 12/30/2020 | ₩1.78 T | 25.14% | 6016 |
| 12/30/2019 | ₩1.42 T | -27.06% | 6089 |
| 12/28/2018 | ₩1.95 T | 14.59% | 4396 |
| 12/28/2017 | ₩1.7 T | 139.45% | 5344 |
| 12/29/2016 | ₩709.04 B | -3.38% | 8895 |
Company Profile
About Daewoong Pharmaceutical Co., Ltd.
Daewoong Pharmaceutical Co., Ltd. is a leading pharmaceutical company based in Seoul, South Korea. Established in 1945, the company specializes in the manufacturing and distribution of a diverse range of pharmaceutical products, serving both domestic and international markets.
Key Product Offerings
- Therapeutic Areas: Central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases.
- Supplements: Iron supplements and multi-vitamins.
- Medical Devices: COVID-19 PCR kits, COVID-19 IgG/IgM RDT, and viral transport medium solutions.
With decades of expertise, Daewoong Pharmaceutical continues to innovate and deliver high-quality healthcare solutions to improve patient outcomes worldwide.
Frequently Asked Questions
-
What is Daewoong Pharmaceutical Co., Ltd's (KRX-069620) current market cap?As of 06/18/2025, Daewoong Pharmaceutical Co., Ltd (including the parent company, if applicable) has an estimated market capitalization of $1.3 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Daewoong Pharmaceutical Co., Ltd (KRX-069620) rank globally by market cap?Daewoong Pharmaceutical Co., Ltd global market capitalization ranking is approximately 8022 as of 06/18/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.